Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this randomized trial was to investigate whether early initiation of
treatment with Risperdal Consta after an acute episode was not inferior to the routine
approach (oral treatment for 12 weeks followed by treatment with Risperdal Consta). .